Opportunities and challenges for targeted radionuclide therapy of prostate cancer using 161Tb
Language
EN
Article de revue
This item was published in
Médecine Nucléaire. 2023-10-05, vol. 47, n° 6, p. 333-338
English Abstract
161Tb has aroused great interest to improve response rate of targeted radionuclide therapy due to its unique decay features. In this review article, decay properties of medically relevant radionuclides of the terbium element ...Read more >
161Tb has aroused great interest to improve response rate of targeted radionuclide therapy due to its unique decay features. In this review article, decay properties of medically relevant radionuclides of the terbium element are first described. Next, modeling studies, production, preclinical and clinical studies performed using 161Tb in prostate cancer are reviewed.Read less <
English Keywords
Prostate cancer
Therapy
ANR Project
Initiative d'excellence de l'Université de Bordeaux - ANR-10-IDEX-0003